Slingshot members are tracking this event:

Phase 1/2 trial updated data of LentiGlobin for β-Thalassemia and Sickle Disease expected at ASH December 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 05, 2016
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 1/2 Trial, Lentiglobin, Beta-thalassemia, Ash 2016